| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.71M | $49.17M | - | |
| CEO | ROBINS CHAD M | 2.58M | $46.90M | -124,998 |
| Other | 1.23M | $22.37M | - | |
| Other | ROBINS HARLAN S | 1.22M | $22.18M | -10,000 |
| COO | RUBINSTEIN JULIE | 607.7K | $11.03M | - |
| Other | LO FRANCIS | 352.6K | $6.40M | -82,715 |
| Other | BOBULSKY SUSAN | 347.2K | $6.30M | - |
| Other | BENZENO SHARON | 301.1K | $5.46M | - |
| CFO | 281.3K | $5.11M | - | |
| Dir | 234.7K | $4.26M | - | |
| CFO | PISKEL KYLE | 220.9K | $4.01M | -4,290 |
| Dir | NEUPERT PETER M | 184.7K | $3.35M | - |
| Dir | OWEN KATEY EINTERZ | 72.6K | $1.32M | - |
| Dir | 69.7K | $1.26M | - | |
| Dir | HERSHBERG ROBERT | 46.7K | $848.0K | - |
| Dir | 15.4K | $279.4K | - |
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2021-04-30 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 4,166 | $41.93 | $174,680.38 | -21.7% | → |
| 2021-04-22 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 27,265 | $41.56 | $1,133,211.60 | -5.1% | → |
| 2021-04-19 | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | Sale+OE | 1,301 | $41.25 | $53,666.25 | -12.4% | → |
| 2021-04-15 | LO FRANCIS | Chief People Officer | Sale+OE | 2,000 | $43.04 | $86,080.00 | -8.8% | → |
| 2021-04-14 | BALDO LANCE | Chief Medical Officer | Sale+OE | 2,000 | $44.50 | $89,000.00 | -8.0% | → |
| 2021-04-14 | GRIFFIN MICHELLE RENEE | Director | Sale+OE | 4,500 | $43.41 | $195,345.00 | -75.0% | → |
| 2021-04-08 | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $41.81 | $627,106.72 | -0.1% | → |
| 2021-04-07 | ADAMS R MARK | Chief Operating Officer | Sell | 3,586 | $42.34 | $151,831.24 | -5.1% | → |
| 2021-04-07 | Cohen Chad M | Chief Financial Officer | Sale+OE | 20,000 | $41.30 | $826,004.50 | -23.4% | → |
| 2021-03-31 | Taylor Stacy L | SVP and General Counsel | Sale+OE | 4,167 | $40.00 | $166,680.00 | -21.7% | → |
| 2021-03-25 | ROBINS HARLAN S | Chief Scientific Officer | Sale+OE | 19,475 | $40.36 | $786,060.54 | -4.4% | → |
| 2021-03-19 | ROBINS CHAD M | CEO and Chairman | Sell | 15,000 | $42.89 | $643,416.31 | -0.1% | → |
| 2021-03-18 | Palaniappan Jyoti | SVP, Diagnostics, immunoSEQ Dx | Sale+OE | 16,052 | $43.58 | $699,560.09 | -30.3% | → |
| 2021-03-16 | GRIFFIN MICHELLE RENEE | Director | Sale+OE | 6,000 | $43.06 | $258,363.48 | -42.5% | → |
| 2021-03-15 | LO FRANCIS | Chief People Officer | Sale+OE | 2,000 | $41.83 | $83,656.12 | -4.5% | → |
| 2021-03-15 | BENZENO SHARON | Chief Business Development Off | Sale+OE | 1,354 | $41.69 | $56,450.70 | -2.8% | → |
| 2021-03-10 | Cohen Chad M | Chief Financial Officer | Sale+OE | 10,000 | $42.54 | $425,400.00 | -31.6% | → |